Stimcell Energetics (STME) Amortization - Intangibles (2016 - 2017)
Stimcell Energetics' quarterly Amortization - Intangibles came in at $336.0 in Q2 2017, down 96.23% quarter-over-quarter from $8906.0 in Q1 2017.
Stimcell Energetics has reported Amortization - Intangibles for 2 years, with the latest figure at $336.0 in Q2 2017.
- For the quarter ending Q2 2017, Amortization - Intangibles changed N/A year-over-year to $336.0; the trailing twelve-month figure through May 2017 stood at $22972.0 (changed N/A YoY), and the FY2017 full-year result was $22972.0, up 356.88% from the prior year.
- Amortization - Intangibles for Q2 2017 stood at $336.0, down from $8906.0 in the prior quarter.
- The five-year high for Amortization - Intangibles was $8906.0 in Q1 2017, with the low at $336.0 in Q2 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Stimcell Energetics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2017 | 336.00 |
| Feb 28, 2017 | 8,906.00 |
| Nov 30, 2016 | 7,473.00 |
| Aug 31, 2016 | 6,257.00 |